Kerry Levan Blanchard
Keine laufenden Positionen mehr
Vermögen: 24 Mio $ am 31.03.2024
Profil
Kerry Levan Blanchard is the founder of Perpetual Medicines Corp.
Currently, he holds director positions at Everest Medicines II Ltd., EverNov Medicines (Zhuhai Hengqin) Co. Ltd., Everstar Medicines Shanghai Ltd., and is an operating partner at CBC Group Co., Ltd.
Previously, he served as the Chief Executive Officer & Executive Director at Everest Medicines Ltd.
from 2020 to 2022, Chief Science Officer at Innovent Biologics, Inc. in 2018-2019, and Senior Vice President at Lilly China Research & Development Co. Ltd.
from 2000 to 2017.
He was also an Associate Professor at Louisiana State University from 1992 to 1999 and a Director at Zymeworks BC, Inc. He received his undergraduate degree in 1977 and his doctorate in 1985 from Indiana University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EVEREST MEDICINES LTD.
2,43% | 26.08.2022 | 7 873 499 ( 2,43% ) | 24 Mio $ | 31.03.2024 |
Aktive Positionen von Kerry Levan Blanchard
| Unternehmen | Position | Beginn |
|---|---|---|
| CBC Group Co., Ltd. | Corporate Officer/Principal | - |
Everest Medicines II Ltd.
 Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Everest Medicines II Ltd. develops and commercializes pharmaceutical products. The private company is based in Road Town, Cayman Islands. | Director/Board Member | - |
| EverNov Medicines (Zhuhai Hengqin) Co. Ltd. | Director/Board Member | - |
| Everstar Medicines Shanghai Ltd. | Director/Board Member | - |
Ehemalige bekannte Positionen von Kerry Levan Blanchard
| Unternehmen | Position | Ende |
|---|---|---|
| EVEREST MEDICINES LIMITED | Chief Executive Officer | 26.08.2022 |
| INNOVENT BIOLOGICS, INC. | Chief Tech/Sci/R&D Officer | 01.06.2019 |
Lilly China Research & Development Co. Ltd.
 Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The private company is based in Shanghai, China. | Corporate Officer/Principal | 01.12.2017 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Director/Board Member | 10.05.2017 |
| Louisiana State University | Corporate Officer/Principal | 01.01.1999 |
Ausbildung von Kerry Levan Blanchard
| Indiana University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INNOVENT BIOLOGICS, INC. | Health Technology |
| EVEREST MEDICINES LIMITED | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Lilly China Research & Development Co. Ltd.
Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The private company is based in Shanghai, China. | Health Technology |
| CBC Group Co., Ltd. | |
Everest Medicines II Ltd.
Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Everest Medicines II Ltd. develops and commercializes pharmaceutical products. The private company is based in Road Town, Cayman Islands. | Health Technology |
| EverNov Medicines (Zhuhai Hengqin) Co. Ltd. | |
| Everstar Medicines Shanghai Ltd. |
